Jyong Biotech【MENS】銘柄情報

Jyong Biotech Ltd (MENS) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

2.20

( 17.02% )

買値

2.03

売値

2.24

出来高

171,571

1.90 日の範囲 2.24

1.43 52 週間の範囲 67.00

時価総額

163.313M

前日終値

1.88

始値

1.90

時刻

2.03

最終取引時間

財務取引量

US$ 361,470

VWAP

2.1068

平均取引量 (3 か月)

US$ 109,159

発行済株式数

74,233,409

配当利回り

PER

-29.39

1 株当たり利益 (EPS)

-0.06

歳入

純利益

-4.67M

Jyong Biotech Ltd., a science-driven biotechnology company, engages in the development and commercialization of plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. It develops Botreso, for the treatment of benign prostate hyperplasia/l... Jyong Biotech Ltd., a science-driven biotechnology company, engages in the development and commercialization of plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. It develops Botreso, for the treatment of benign prostate hyperplasia/lower urinary tract symptoms; PCP for treating prostate cancer; and interstitial cystitis (IC) for the treatment of IC/bladder pain syndrome. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

jyongbio.com

本社

New Taipei City, Taiwan

設立

2026

Jyong Biotech Ltd is listed in the Healthcare sector of the ナスダック市場 with ticker MENS. The last closing price for Jyong Biotech was US$1.88. Over the last year, Jyong Biotech shares have traded in a share price range of US$ 1.43 to US$ 67.00.

Jyong Biotech currently has 74,233,409 shares in issue. The market capitalisation of Jyong Biotech is US$163.31 million. Jyong Biotech has a price to earnings ratio (PE ratio) of -29.39.

Jyong Biotech Updates Market Access Strategy for Innovative Botanical Drugs, Establishing Multiple Competitive Advantages for New Drug Portfolio

New Taipei City, Taiwan, April 28, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company”...

Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership

Form 3 - Initial statement of beneficial ownership of securities

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.6	37.5	1.6	2.215	1.544	224614	1.77747597	CS
4	0.01	0.456621004566	2.19	2.2791	1.5006	159990	1.7512399	CS
12	-0.28	-11.2903225806	2.48	3	1.5006	102319	2.03587742	CS
26	-0.97	-30.5993690852	3.17	5.35	1.43	270891	2.70481821	CS
52	-7.07	-76.2675296656	9.27	67	1.43	392666	16.14258971	CS
156	-5.91	-72.8729963009	8.11	67	1.43	386874	16.07487612	CS
260	-5.91	-72.8729963009	8.11	67	1.43	386874	16.07487612	CS